Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Monoxide, Mononitrogen

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Beyond Cancer Unveils Phase 1 UNO Data at AACR 2026
    Beyond Cancer Unveils Phase 1 UNO Data at AACR 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232002/0/en/Beyond-Cancer-Abstract-Featuring-Phase-1-Data-on-Intratumoral-Ultra-High-Concentration-Nitric-Oxide-UNO-in-Solid-Tumor-Metastases-to-be-Presented-at-the-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Beyond Air to Attend Two Upcoming Healthcare Investor Conferences
    Beyond Air to Attend Two Upcoming Healthcare Investor Conferences

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3227075/0/en/Beyond-Air-to-Participate-in-Two-Upcoming-Healthcare-Investor-Conferences.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Beyond Air Sets Q3 Financial Results Conference Call, Webcast
    Beyond Air Sets Q3 Financial Results Conference Call, Webcast

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225973/0/en/Beyond-Air-Schedules-Third-Fiscal-Quarter-2026-Financial-Results-Conference-Call-and-Webcast.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Beyond Air Announces $5M Private Placement Under Nasdaq Rules
    Beyond Air Announces $5M Private Placement Under Nasdaq Rules

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218639/0/en/Beyond-Air-Announces-5-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Beyond Air Signs Lungfit PH Distribution Deals In Germany
    Beyond Air Signs Lungfit PH Distribution Deals In Germany

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206903/0/en/Beyond-Air-Signs-New-International-LungFit-PH-Distribution-Agreements-Most-Notably-in-Germany-and-Brazil.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Biossil Acquire Galera Therapeutics' Dismutase Mimetics portfolio
    Biossil Acquire Galera Therapeutics' Dismutase Mimetics portfolio

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170932/0/en/Galera-Therapeutics-Announces-Acquisition-of-Dismutase-Mimetics-Portfolio-by-Toronto-based-Biossil-for-up-to-105-Million.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.